HUTCHMED (HCM)

• Market cap: $1.86B
• 1 day: -1.19%
• 5 days: -0.46%
• 1 month: -13.43%
• 3 months: -24.16%
• 6 months: -18.75%
• Year to date: -20.66%
• 1 year: -35.5%
• 5 years: -63.57%
• 10 years: -23.62%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Employees: 1,796